- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Moderate to Severe Plaque Psoriasis in United Kingdom
Total 480 results
-
Memorial Sloan Kettering Cancer CenterWeizmann Institute of Science; Steba Biotech S.A.Active, not recruitingEsophagogastric Cancer | Moderate to Severe DysphagiaIsrael, United States
-
Genentech, Inc.TerminatedModerate-to-severe Allergic AsthmaUnited States
-
Wake Forest UniversityCompleted
-
AmgenRecruitingPlaque PsoriasisUnited States
-
Hangzhou Highlightll Pharmaceutical Co., LtdRecruitingPlaque PsoriasisUnited States
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedActive Plaque PsoriasisUnited States, Germany, Israel
-
UCB Biopharma SRLCompletedChronic Plaque PsoriasisUnited States, Australia, Canada, Moldova, Republic of
-
SandozHexal AGCompletedChronic Stable Plaque PsoriasisGermany, Romania, Bulgaria, Czech Republic, Estonia, Hungary, Poland, Russian Federation, Slovakia, South Africa, Ukraine, United Kingdom
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States, Georgia, Ukraine
-
TakedaRecruitingPlaque PsoriasisUnited States, Canada, Poland
-
UCB Biopharma S.P.R.L.CompletedPsoriasis | Plaque PsoriasisUnited States, Austria, Canada, Poland
-
Alumis IncEnrolling by invitationPlaque PsoriasisUnited States, Canada
-
AmgenCompletedPlaque PsoriasisUnited States, Canada
-
PfizerTerminatedPlaque PsoriasisUnited States, Canada
-
MedImmune LLCCompletedPlaque PsoriasisUnited States, Canada
-
UCB Biopharma S.P.R.L.CompletedPsoriasis | Plaque PsoriasisUnited States, Canada, Czechia, Germany, Hungary
-
Solta MedicalCompleted
-
AmgenTerminatedModerate to Severe Rheumatoid ArthritisUnited States, Canada, Puerto Rico
-
Alumis IncCompletedPlaque PsoriasisUnited States, Canada, Czechia
-
Dermavant Sciences GmbHIQVIA BiotechCompletedPlaque PsoriasisUnited States, Canada
-
Akron Children's HospitalCompletedChildrens 0 to 18 Years of Age Who Require Moderate SedationUnited States
-
University of California, San FranciscoCompletedChronic Stable Plaque PsoriasisUnited States
-
Hoffmann-La RochePfizerCompletedModerate to Severe Ulcerative ColitisUnited States, Australia, Thailand, Poland, Russian Federation, Japan, Colombia, Spain, Turkey, Romania, India, Slovakia, France, Hungary, South Africa, Belgium, Bulgaria, Germany, Italy, Mexico, Serbia, Ukraine, United Kingdom
-
Incyte CorporationCompletedPlaque PsoriasisUnited States, Canada
-
Indivior Inc.Active, not recruitingModerate to Severe Opioid-use DisorderUnited States, Canada
-
Mayne Pharma International Pty LtdCompletedPlaque PsoriasisUnited States, Poland, Ukraine, Georgia
-
AmgenCompletedPlaque PsoriasisUnited States, Canada, Poland, Estonia, Germany, Hungary, Latvia, Lithuania
-
Janssen Research & Development, LLCRecruitingPlaque PsoriasisUnited States, Korea, Republic of, Taiwan, Germany, Poland, Brazil, Spain, Hungary, Australia, Canada, Romania
-
Eli Lilly and CompanyCompletedPlaque PsoriasisUnited States, Spain, Puerto Rico, Czechia, Canada, Germany, France, Poland, Hungary, Mexico, Russian Federation, Argentina, Netherlands
-
Incyte CorporationRecruitingModerate to Severe AsthmaKorea, Republic of, United States, Spain, Poland, Japan, Canada, Germany, Belgium, Argentina
-
Dermavant Sciences GmbHIQVIA BiotechCompletedPlaque PsoriasisUnited States, Canada
-
UCB Biopharma SRLParexelCompletedChronic Plaque PsoriasisUnited States, Australia, Canada, Moldova, Republic of
-
AbbVie (prior sponsor, Abbott)CompletedPlaque PsoriasisUnited States, Canada
-
AmgenCompletedPsoriasis | Plaque-type PsoriasisUnited States, Canada
-
AbbottCompletedChronic Plaque PsoriasisBelgium, Denmark, France, Germany, Spain, Sweden, Switzerland, Finland, Turkey, Italy, Czech Republic, Austria, Netherlands, United Kingdom, Greece
-
Sun Pharmaceutical Industries LimitedTerminatedPlaque PsoriasisUnited States
-
Galderma R&DCompletedChronic Plaque PsoriasisUnited States, Canada
-
Astellas Pharma IncCompletedChronic Plaque PsoriasisUnited States, Canada
-
Novartis PharmaceuticalsCompletedChronic Plaque Type PsoriasisGermany, United States, Belgium, Korea, Republic of, Spain, Taiwan, Australia, Austria, Italy, Estonia, Israel, Bulgaria, Netherlands, France, Switzerland, Portugal, Slovakia, Norway, United Kingdom, Hungary, Turkey, Canada, Denmark, ...
-
PfizerCompletedChronic Plaque PsoriasisUnited States, Poland, Canada
-
Astellas Pharma IncBiogenCompletedChronic Plaque PsoriasisUnited States, Austria, Germany, Belgium, Canada
-
Novartis PharmaceuticalsCompleted
-
UCB Biopharma S.P.R.L.ParexelCompletedChronic Plaque PsoriasisUnited States, Canada, Czechia, Hungary, Japan, Poland
-
Cytos Biotechnology AGTerminatedModerate to Severe Allergic AsthmaUnited States, Czech Republic, Germany, Hungary, Israel, Poland, Russian Federation, Ukraine
-
AbbViePPDRecruitingPlaque Psoriasis | Crohn Disease | Psoriatic Arthritis | Other Conditions for Which Risankizumab is an FDA-approved TreatmentUnited States
-
Arcutis Biotherapeutics, Inc.CompletedChronic Plaque PsoriasisUnited States, Canada
-
Novartis PharmaceuticalsCompletedChronic Plaque PsoriasisGermany, United States, Colombia, Italy, Spain, Belgium, Egypt, Hungary, Australia, Singapore, France, Sweden, Guatemala, Philippines, Korea, Republic of, United Kingdom, Argentina, Poland, Romania, Canada, Iceland, India, Finland
-
Novartis PharmaceuticalsCompletedPlaque PsoriasisGermany, Belgium, Spain, Croatia, Czechia, Greece, Hungary, Russian Federation, Netherlands, Austria, France, Switzerland, Israel, United Kingdom, Italy, Lithuania, Sweden, Bulgaria, Denmark, Finland, Portugal, Slovakia, Poland, Latvia
-
Novartis PharmaceuticalsCompletedChronic Plaque-type PsoriasisUnited States
-
Arcutis Biotherapeutics, Inc.CompletedPlaque PsoriasisUnited States, Canada